Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2834
https://www.novonordisk.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S (ADR)
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
- Apr 24th, 2024 9:50 am
About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows
- Apr 24th, 2024 9:01 am
Novo Nordisk (NVO) Boasts Earnings & Price Momentum: Should You Buy?
- Apr 23rd, 2024 1:30 pm
Why Novo Nordisk Topped the Market Today
- Apr 22nd, 2024 10:08 pm
Lilly to buy injectable drug plant in manufacturing ramp-up
- Apr 22nd, 2024 5:50 pm
Novo Nordisk A/S - share repurchase programme
- Apr 22nd, 2024 1:06 pm
2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever
- Apr 20th, 2024 1:45 pm
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
- Apr 20th, 2024 12:30 pm
3 Relatively Safe Growth Stocks You Can Buy and Hold
- Apr 20th, 2024 10:48 am
Weight loss drugs and the many use cases in medical treatments
- Apr 19th, 2024 9:32 pm
Got $500? 3 Healthcare Stocks to Buy and Hold Forever
- Apr 19th, 2024 12:15 pm
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
- Apr 18th, 2024 8:02 pm
India's Biocon developing its own version of Wegovy, clinical trial likely next year
- Apr 18th, 2024 4:23 pm
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
- Apr 18th, 2024 4:01 pm
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
- Apr 18th, 2024 12:51 pm
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo
- Apr 18th, 2024 7:00 am
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
- Apr 17th, 2024 8:30 am
Novo Nordisk (NVO) Stock Falls Amid Market Uptick: What Investors Need to Know
- Apr 16th, 2024 9:45 pm
The Zacks Analyst Blog Highlights Microsoft, Novo Nordisk, United Parcel Service, Booking and Elevance Health
- Apr 16th, 2024 9:07 am
3 Pharma Stocks That Are Money-Printing Machines in 2024
- Apr 15th, 2024 9:51 pm
Scroll